CAS: 1380672-07-0 - G007-LK
Benzonitrile, 4-[5-[(1E)-2-[4-(2-chlorophenyl)-5-[5-(methylsulfonyl)-2-pyridinyl]-4H-1,2,4-triazol-3-yl]ethenyl]-1,3,4-oxadiazol-2-yl]-
CAS:1380672-07-0
Fórmula:
C25H16ClN7O3S
Pureza:
%
Forma y color:
Solid
Peso molecular:
529.9576
Ref: IN-DA0017XO
5mg | 67,00 € | ||
10mg | 110,00 € | ||
25mg | 151,00 € | ||
50mg | 217,00 € | ||
100mg | 488,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
G007-LK
CAS:1380672-07-0
G007-LK is a selective inhibitor of TNKS1 and TNKS2, with IC50s of 46 nM and …
Fórmula:
C25H16ClN7O3S
Pureza:
98.17% - 98.62%
Forma y color:
Solid
Peso molecular:
529.96
Ref: TM-T6842
1mg | 49,00 € | ||
2mg | 70,00 € | ||
5mg | 97,00 € | ||
10mg | 164,00 € | ||
25mg | 330,00 € | ||
50mg | 524,00 € | ||
100mg | 737,00 € | ||
1mL*10mM (DMSO) | 122,00 € |
Entrega estimada en Estados Unidos, el Lunes 16 de Diciembre de 2024
(E)-4-(5-(2-(4-(2-Chlorophenyl)-5-(5-(methylsulfonyl)pyridin-2-yl)-4H-1,2,4-triazol-3-yl)vinyl)-1,3,4-oxadiazol-2-yl)benzonitrile
CAS:1380672-07-0
(E)-4-(5-(2-(4-(2-Chlorophenyl)-5-(5-(methylsulfonyl)pyridin-2-yl)-4H-1,2,4-triazol-3-yl)vinyl)-1,3,4-oxadiazol-2-yl)benzonitrile is a drug candidate for the treatment of cancer. It has a pharmacokinetic profile …
Fórmula:
C25H16ClN7O3S
Pureza:
Min. 95%
Peso molecular:
529.97 g/mol
Ref: 3D-FFC67207
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025